Product Details

Verokcl is a sterile, pyrogen-free injectable concentrate that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Potassium Chloride at 1.5% w/v (0.2 mmol K⁺ per mL) for intravenous infusion after dilution. As a result, it offers a reliable electrolyte replacement solution for the correction of potassium deficiency in hospital settings.

The injection contains:

• Potassium Chloride BP (1.5% w/v, equivalent to 0.2 mmol K⁺ per mL) – An essential electrolyte that restores intracellular and extracellular potassium concentrations. Consequently, it supports normal neuromuscular function, cardiac conduction, and acid-base balance once diluted and infused appropriately.

Physicians use Verokcl for the treatment and prevention of hypokalaemia, particularly in patients unable to maintain adequate potassium intake orally or those experiencing potassium losses from diuretic therapy, gastrointestinal losses, or other clinical conditions. However, this concentrate must always be diluted in a suitable IV fluid before administration and given as a slow, controlled infusion — never as a direct injection or bolus. Because of this strict handling requirement, Verokcl suits hospital pharmacies, ICUs, and clinical settings with the infrastructure to prepare and monitor diluted electrolyte infusions safely.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the sterile, pyrogen-free concentrate supports safe preparation for IV infusion
• Furthermore, each vial delivers precise, validated dosage accuracy at 0.2 mmol K⁺ per mL
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, the single-use vial format minimizes contamination risk
• Critically, this is a concentrate that requires dilution before use and must never be administered undiluted
• Ultimately, a reliable supply chain suits bulk distribution to hospitals and clinical pharmacies